Clinical Trial Update: WaKING: Wnt and checKpoint INhibition in Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial WaKING is a Phase 1/Phase 2 study investigating Wnt pathway inhibition in combination with checkpoint blockade for metastatic esophageal and gast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Metastatic Esophageal Cancer, Metastatic Gastric Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING